Lazard Asset Management
EVH icon

Lazard Asset Management’s Evolent Health EVH Stock Holding History

Lazard Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.4K Sell
16,123
-93,500
-85% -$358K ﹤0.01% 1766
2026
Q1 		$250K Sell
109,623
-239,799
-69% -$761K ﹤0.01% 1565
2025
Q4 		$1.4M Sell
349,422
-395,469
-53% -$2.2M ﹤0.01% 1041
2025
Q3 		$6.3M Buy
744,891
+106,534
+17% +$1.03M 0.01% 520
2025
Q2 		$7.19M Buy
638,357
+39,516
+7% +$363K 0.01% 630
2025
Q1 		$5.67M Sell
598,841
-45,956
-7% -$464K 0.01% 648
2024
Q4 		$7.25M Sell
644,797
-1,726,255
-73% -$30.3M 0.01% 544
2024
Q3 		$67.1M Buy
2,371,052
+2,007,004
+551% +$51.7M 0.09% 164
2024
Q2 		$6.96M Buy
364,048
+80,590
+28% +$2.06M 0.01% 597
2024
Q1 		$9.29M Buy
283,458
+174,826
+161% +$5.58M 0.01% 553
2023
Q4 		$3.59M Buy
+108,632
New +$3.07M ﹤0.01% 746
2020
Q1 		– Sell
-3,140
Closed -$28K – 1620
2019
Q4 		$28K Buy
3,140
+2,775
+760% +$22.5K ﹤0.01% 1167
2019
Q3 		$2K Sell
365
-335
-48% -$2.4K ﹤0.01% 1397
2019
Q2 		$5K Hold
700
– – ﹤0.01% 1169
2019
Q1 		$8K Sell
700
-238,500
-100% -$3.78M ﹤0.01% 1102
2018
Q4 		$4.77M Sell
239,200
-24,380
-9% -$564K 0.01% 544
2018
Q3 		$7.49M Buy
263,580
+4,455
+2% +$106K 0.01% 499
2018
Q2 		$5.45M Sell
259,125
-348,780
-57% -$6.6M 0.01% 546
2018
Q1 		$8.66M Buy
+607,905
New +$8.7M 0.01% 461

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lazard Asset Management's EVH Position: Q2 2026 in Review

Lazard Asset Management reduced its Evolent Health (EVH) stake by 85% in Q2 2026, selling an estimated $358K and leaving 16,123 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1766.

Lazard Asset Management first reported a position in EVH in Q1 2018 and has held it in 19 quarters since. The position peaked at $67.1M in Q3 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Lazard Asset Management held 16,123 shares of Evolent Health worth $87.4K as of Q2 2026.
  • Lazard Asset Management sold 93,500 Evolent Health shares in Q2 2026, an estimated $358K.
  • Evolent Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1766 holding.
  • Lazard Asset Management first reported a position in Evolent Health in Q1 2018 and has held it in 19 quarters since.
  • Lazard Asset Management's Evolent Health position peaked at $67.1M in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.